Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 16/20 | 0.40 |
| ▸ | GPR183 | P32249 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.36 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1724851 | 1.00 | GPR119 (0.40) | GPR119GPR183KCNH2ACACBCYP4F2 | |
| SCHEMBL150987 | 0.92 | GPR119 (0.39) | GPR119GPR183KCNH2ACACB | |
| SCHEMBL150986 | 0.92 | GPR119 (0.39) | GPR119GPR183KCNH2ACACB | |
| SCHEMBL120032 | 0.87 | GPR119 (0.42) | GPR119GPR183KCNH2 | |
| SCHEMBL147767 | 0.87 | GPR119 (0.42) | GPR119GPR183KCNH2 | |
| SCHEMBL151482 | 0.84 | GPR119 (0.34) | GPR119GPR183KCNH2 | |
| SCHEMBL151484 | 0.84 | GPR119 (0.34) | GPR119GPR183KCNH2 | |
| SCHEMBL151483 | 0.84 | GPR119 (0.34) | GPR119GPR183KCNH2 | |
| SCHEMBL148829 | 0.82 | GPR119 (0.35) | GPR119GPR183KCNH2ACACB | |
| SCHEMBL122219 | 0.78 | DPP4 (0.41) | GPR119GPR183KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2406251-A1 | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | Prosidion Limited (GB) | 2012-01-18 | — | — | EP | disclosed |
| WO-2010103334-A1 | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | PROSIDION LIMITED (GB) | 2010-09-16 | — | — | WO | disclosed |